Drug intelligence / Profile preview

5-[4-tert-butylphenylsulfanyl]-2,4-quinazolinediamine

Development stage
Unknown
Modality
Small Molecules
01

Overview

A synthetic small molecule quinazoline derivative featuring a tert-butyl-substituted phenylthio group at the 5-position and diamino groups at the 2 and 4 positions of the quinazoline core. It is a potent inhibitor of dihydrofolate reductase (DHFR), an enzyme critical for folate metabolism and DNA synthesis. The compound has demonstrated nanomolar inhibitory activity against yeast DHFR (IC50 ~8 nM) and micromolar activity against human DHFR (IC50 ~2000 nM). Its primary mechanism is competitive inhibition of DHFR by binding to its active site. This class of compounds is often explored for potential antitumor or antimicrobial properties due to their ability to disrupt nucleotide biosynthesis[3][1][2].

Other names
5-(4-tert-butylphenyl)sulfanylquinazoline-2,4-diamine5-(4-tert-butylphenylthio)quinazoline-2,4-diamine5-{[4-(2-methyl-2-propanyl)phenyl]sulfanyl}-2,4-chinazolindiamin5-{[4-(2-methyl-2-propanyl)phenyl]sulfanyl}-2,4-quinazolinediamine
02

Targets

DHFR (Dihydrofolate reductase)

Beyond the preview

Go deeper on 5-[4-tert-butylphenylsulfanyl]-2,4-quinazolinediamine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 5-[4-tert-butylphenylsulfanyl]-2,4-quinazolinediamine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call